Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vandenberg

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14Kathleen I Pritchard, Lois E Shepherd, Judith-Anne W Chapman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Breast Cancer Research and Treatment|August 11, 2018
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancerAdrienne E Borrie, Rhiannon V Rose, Yun-Hee Choi, et al.
Breast Cancer Research and Treatment|April 3, 2015
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancerAna Elisa Lohmann, Judy-Anne W Chapman, Margot J Burnell, et al.
Pharmacogenomics|August 24, 2023
Effects of <i>CYP3A4</i> and <i>CYP2C9</i> genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study GroupJ M Nabholtz, H J Senn, W R Bezwoda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2016
Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast CancerHeather A Parsons, Julia A Beaver, Ashley Cimino-Mathews, et al.
Pharmacological Reviews|December 6, 2003
International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channelsGeorge A Gutman, K George Chandy, John P Adelman, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14Kathleen I Pritchard, Lois E Shepherd, Judith-Anne W Chapman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Breast Cancer Research and Treatment|August 11, 2018
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancerAdrienne E Borrie, Rhiannon V Rose, Yun-Hee Choi, et al.
Breast Cancer Research and Treatment|April 3, 2015
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancerAna Elisa Lohmann, Judy-Anne W Chapman, Margot J Burnell, et al.
Pharmacogenomics|August 24, 2023
Effects of <i>CYP3A4</i> and <i>CYP2C9</i> genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study GroupJ M Nabholtz, H J Senn, W R Bezwoda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2016
Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast CancerHeather A Parsons, Julia A Beaver, Ashley Cimino-Mathews, et al.
Pharmacological Reviews|December 6, 2003
International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channelsGeorge A Gutman, K George Chandy, John P Adelman, et al.
Pageof 12